Please login to the form below

Not currently logged in
Email:
Password:

TNF

This page shows the latest TNF news and features for those working in and with pharma, biotech and healthcare.

AbbVie’s upadacitinib aces phase III trial

AbbVie’s upadacitinib aces phase III trial

AbbVie’s JAK1 inhibitor upadacitinib has proved more effective than the company’s widely-used TNF blocker Humira in a phase III trial in rheumatoid arthritis patients, without adding to a

Latest news

More from news
Approximately 1 fully matching, plus 181 partially matching documents found.

Latest Intelligence

  • Customer experience rules the digital age Customer experience rules the digital age

    Take the area of anti-TNFs and their biosimilar competitors. Competition here is becoming fierce and is being led more and more by customers’overall experiences, including service-led patient support

  • Deal Watch December 2016 Deal Watch December 2016

    Not disclosed. Bispecific antibody technology. Exicure. Purdue. $790m. Not disclosed. Spherical Nucleic Acid technology and a topical anti-TNF product.

  • Opening up innovation Opening up innovation

    In much the same way that the last decade saw the anti-TNF treatments for autoimmune conditions become a 'pipeline in a product', Paul-Peter says that with Benlysta GSK has “

  • Cost containment and the German market Cost containment and the German market

    The main sales drivers are biopharmaceutical medicines like the monoclonal antibody adalimumab, TNF-alpha inhibitor etanercept as well as the oncologic drugs imatinib and enzalutamide.

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    Among these are Avaxia Biologics, which is developing an anti-tumour necrosis factor (TNF) antibody for inflammatory bowel disease and UK-based VH Squared, which has an early-stage programme ongoing

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics